DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Symdeko is a prescription medication that combines two active ingredients: tezacaftor and ivacaftor. It is primarily used in the treatment of cystic fibrosis (CF), a genetic disorder that affects the lungs and other organs, leading to the production of thick and sticky mucus.